Third Rock Ventures II, L.P. [Rocket]

Date Filed	Type	Description
02/14/2023	SC 13G/A	Third Rock Ventures II, L.P. reports a 0% stake in Allena Pharmaceuticals, Inc.
02/14/2023	SC 13G/A	Third Rock Ventures II, L.P. reports a 0.6% stake in Jounce Therapeutics, Inc.
02/14/2022	SC 13G/A	Third Rock Ventures II, L.P. reports a 8.1% stake in Jounce Therapeutics, Inc.
02/16/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2019	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018	SC 13G	Third Rock Ventures II, L.P. reports a 13.5% stake in Allena Pharmaceuticals, Inc.
02/13/2018	SC 13G/A	Third Rock Ventures II, L.P. reports a 2.2% stake in Sage Therapeutics, Inc.
02/13/2018	SC 13G/A	Third Rock Ventures II, L.P. reports a 6% stake in Blueprint Medicines Corporation
02/13/2018	SC 13G	Third Rock Ventures II, L.P. reports a 41.2% stake in Jounce Therapeutics, Inc.
02/13/2018	SC 13G/A	Third Rock Ventures II, L.P. reports a 0.7% stake in Global Blood Therapeutics, Inc.
02/13/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2017	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/13/2017	SC 13G/A	Global Blood Therapeutics, Inc. reports a 24% stake in Global Blood Therapeutics, Inc.
02/13/2017	SC 13G/A	MyoKardia Inc reports a 32.1% stake in MYOKARDIA, INC.
02/10/2016	SC 13G	MyoKardia Inc reports a 40.2% stake in MYOKARDIA, INC.
02/10/2016	SC 13G	Blueprint Medicines Corp reports a 24.7% stake in Blueprint Medicines Corporation
02/10/2016	SC 13G	Global Blood Therapeutics, Inc. reports a 48.5% stake in Global Blood Therapeutics, Inc.